Literature DB >> 18299793

Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk.

O Combarros1, P Sánchez-Juan, J A Riancho, I Mateo, E Rodríguez-Rodríguez, J Infante, I García-Gorostiaga, J L Vázquez-Higuera, J Berciano.   

Abstract

A chronic inflammatory process with activation of microglial cells contribute to the neurodegeneration associated with Alzheimer's disease (AD). Estrogen could protect the brain from neurodegeneration by augmenting the secretion of the anti-inflammatory interleukin (IL)-10 from microglial cells. In a case-control study in 231 AD patients and 194 healthy controls, we examined whether the combined effects between the genes coding for aromatase (a critical enzyme in the peripheral synthesis of estrogens) and IL-10 might be responsible for susceptibility to AD. Subjects carrying both the aromatase (5 -UTR) GG and the IL-10 (-1082) GG genotypes had a six times lower risk of developing AD than subjects without these risk genotypes (OR = 0.17, 95% CI = 0.04-0.77, P = 0.02).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299793     DOI: 10.1007/s00702-008-0028-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  17 in total

1.  Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.

Authors:  D Lio; F Licastro; L Scola; M Chiappelli; L M Grimaldi; A Crivello; G Colonna-Romano; G Candore; C Franceschi; C Caruso
Journal:  Genes Immun       Date:  2003-04       Impact factor: 2.676

2.  Age-related influence of common aromatase gene polymorphisms on bone mass of healthy men.

Authors:  Ana Zarrabeitia; María T Zarrabeitia; Carmen Valero; Jesús González-Macías; José A Riancho
Journal:  Bone       Date:  2004-07       Impact factor: 4.398

3.  CYP19 haplotypes increase risk for Alzheimer's disease.

Authors:  R Huang; S E Poduslo
Journal:  J Med Genet       Date:  2006-08       Impact factor: 6.318

Review 4.  Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.

Authors:  V W Henderson
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

Review 5.  Interleukin-10 in the brain.

Authors:  K Strle; J H Zhou; W H Shen; S R Broussard; R W Johnson; G G Freund; R Dantzer; K W Kelley
Journal:  Crit Rev Immunol       Date:  2001       Impact factor: 2.214

Review 6.  Inflammation in neurodegenerative disease--a double-edged sword.

Authors:  Tony Wyss-Coray; Lennart Mucke
Journal:  Neuron       Date:  2002-08-01       Impact factor: 17.173

7.  Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines.

Authors:  Filomena O Dimayuga; Janelle L Reed; Genevieve A Carnero; Chunmei Wang; Edgardo R Dimayuga; Vanessa M Dimayuga; Andrea Perger; Melinda E Wilson; Jeffrey N Keller; Annadora J Bruce-Keller
Journal:  J Neuroimmunol       Date:  2005-04       Impact factor: 3.478

8.  A common polymorphism in the 5'-untranslated region of the aromatase gene influences bone mass and fracture risk.

Authors:  Maria T Zarrabeitia; José L Hernández; Carmen Valero; Ana L Zarrabeitia; Mayte García-Unzueta; José A Amado; Jesús González-Macías; José A Riancho
Journal:  Eur J Endocrinol       Date:  2004-05       Impact factor: 6.664

9.  Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.

Authors:  Beatrice Arosio; Daria Trabattoni; Lorenza Galimberti; Paolo Bucciarelli; Francesca Fasano; Carmen Calabresi; Carlo Lorenzo Cazzullo; Carlo Vergani; Giorgio Annoni; Mario Clerici
Journal:  Neurobiol Aging       Date:  2004-09       Impact factor: 4.673

10.  The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation.

Authors:  Elisabetta Vegeto; Silvia Belcredito; Serena Ghisletti; Clara Meda; Sabrina Etteri; Adriana Maggi
Journal:  Endocrinology       Date:  2006-02-09       Impact factor: 4.736

View more
  9 in total

1.  Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome.

Authors:  Constance Chace; Deborah Pang; Catherine Weng; Alexis Temkin; Simon Lax; Wayne Silverman; Warren Zigman; Michel Ferin; Joseph H Lee; Benjamin Tycko; Nicole Schupf
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Association between rs10046, rs1143704, rs767199, rs727479, rs1065778, rs1062033, rs1008805, and rs700519 polymorphisms in aromatase (CYP19A1) gene and Alzheimer's disease risk: a systematic review and meta-analysis involving 11,051 subjects.

Authors:  Yuxuan Song; Yi Lu; Zhen Liang; Yongjiao Yang; Xiaoqiang Liu
Journal:  Neurol Sci       Date:  2019-07-05       Impact factor: 3.307

3.  Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution.

Authors:  Beatrice Arosio; Luigina Mastronardi; Carlo Vergani; Giorgio Annoni
Journal:  Int J Alzheimers Dis       Date:  2010-07-20

Review 4.  Neuroprotective actions of brain aromatase.

Authors:  Colin J Saldanha; Kelli A Duncan; Bradley J Walters
Journal:  Front Neuroendocrinol       Date:  2009-05-18       Impact factor: 8.606

5.  The sex-specific associations of the aromatase gene with Alzheimer's disease and its interaction with IL10 in the Epistasis Project.

Authors:  Christopher Medway; Onofre Combarros; Mario Cortina-Borja; Helen T Butler; Carla A Ibrahim-Verbaas; Renée F A G de Bruijn; Peter J Koudstaal; Cornelia M van Duijn; M Arfan Ikram; Ignacio Mateo; Pascual Sánchez-Juan; Michael G Lehmann; Reinhard Heun; Heike Kölsch; Panos Deloukas; Naomi Hammond; Eliecer Coto; Victoria Alvarez; Patrick G Kehoe; Rachel Barber; Gordon K Wilcock; Kristelle Brown; Olivia Belbin; Donald R Warden; A David Smith; Kevin Morgan; Donald J Lehmann
Journal:  Eur J Hum Genet       Date:  2013-06-05       Impact factor: 4.246

6.  Aromatase variants modify risk for Alzheimer's disease in a multiethnic female cohort.

Authors:  S C Janicki; N Park; R Cheng; N Schupf; L N Clark; J H Lee
Journal:  Dement Geriatr Cogn Disord       Date:  2013-04-18       Impact factor: 2.959

7.  Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis.

Authors:  Myung-Jin Mun; Jin-Ho Kim; Ji-Young Choi; Won-Cheoul Jang
Journal:  Meta Gene       Date:  2016-01-11

Review 8.  Aromatase in the Human Brain.

Authors:  Iñigo Azcoitia; Pablo Mendez; Luis M Garcia-Segura
Journal:  Androg Clin Res Ther       Date:  2021-12-23

Review 9.  Cognitive Effects of Aromatase and Possible Role in Memory Disorders.

Authors:  Cheryl S Rosenfeld; Dusti A Shay; Victoria J Vieira-Potter
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-17       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.